
From One-Size-Fits-All to Personalised Care
Partnered with:
.png)
.png)






Room A5
13:30 - 15:00
English
Artificial intelligence and large-scale data analytics are accelerating the shift from one-size-fits-all care to precision medicine—tailoring treatments to each patient’s genomic and personal profile. This session will examine the regulatory, ethical, and operational challenges of making personalized care accessible and sustainable, and highlight emerging global approaches shaping the future of individualized healthcare.
Opening Remarks
Panel: The Opportunity Ahead: Personalized Care Re-Defined
Moderator:

Dr. Neomi Siegal
Head of Medical Resources Division, Maccabi Health Care
The Israeli Society for HealthTech

Prof. Shay Ben-Shachar
Director Of Precision Medicine and Genomics
Clalit Innovation

Reut Shema
Partner
aMoon Fund

Prof. Lina Basel Salmon
Director of Research and Innovation in Genomic Medicine
Maccabi Healthcare

Dr. Ariella Toren
Senior Manager, Medical Technologies at HMO's Supervision Division
Ministry of Health, Israel
Choose Your Roundtable
While data, diagnostics, and targeted therapies increasingly enable individualized care, healthcare systems remain organized around population averages, fixed budgets, and static reimbursement models. This roundtable reframes the challenge not as a question of innovation, but of institutional readiness: who carries risk, how value is measured, and how systems adapt without undermining equity or sustainability.

Neomi Siegal
Head of Medical Resources Division, Maccabi Health Care
The Israeli Society for HealthTech

Dr Noa Geffen
Head of Pharma Israel & Country Lead Israel
Sanofi

Dr Ariella Toren
Senior Manager, Medical Technologies at HMO's Supervision Division
Ministry of Health Israel.

Oren Pearlsman
Healthcare Professional
If personalized medicine doesn't work for women, it doesn't work. This roundtable explores the double bind: women are both missing from the data and oversimplified when included. Through examples in therapeutics, diagnostics, and AI, we'll identify where the system breaks and what's needed to build scalable, equitable solutions.

Michal Lebenthal Andreson
Co Founder & CEO
Impact.51

Michal Shalem
Co Founder & CEO
Impact.51

Yonit Golub Serkin
Investor and Chief Business Officer
embARC Ventures

Dr. Orna Berry
Former Chief Scientist
Government of Israel
Despite significant advances in genomic technologies and growing evidence of their potential clinical value, personalized genomic medicine has not yet been fully integrated into routine healthcare. This roundtable focuses on the real-world use of genomics, where gaps remain, and how it can be responsibly scaled within health systems.

Rotem Greenberg
Head of the Clinical Genetics
Innovation Division, Clalit Health Services

Dr. Amit Shraga
Head of Data Science, Medical School
Weizmann Institute of Science

Prof. Shay Ben-Shachar
Department Head: Genomics & Precision Medicine
Clalit Innovation

Dr.Karina Furmanov
Medical Head Immunology
Abbvie
This roundtable will focus on data and personalization in healthcare, a foundational element of modern medical care delivery. Meaningful personalization depends not only on advanced analytics and AI capabilities, but critically on the availability of high-quality, interoperable and longitudinal data supported by governance frameworks. Despite rapid technological progress, real-world implementation remains challenging. Regulatory constraints, fragmented data infrastructure, limited interoperability and difficulties integrating personalized insights into everyday clinical workflows continue to impede impact at scale. The discussion will explore how cross-sector collaboration between healthcare systems, industry, academia and policymakers is essential to translating personalization into measurable clinical benefit.

Moderator:
Prof. Lina Basel-Salmon
Director of Research and Innovation in Genomic Medicine
Maccabi Healthcare

Anat Atlas
Director of Data Strategy
Maccabi Healthcare

Renana Ashkenazi
Managing Partner
Grove Ventures

Tali Yavin-Surasky
Partner
Meitar

Dr. Moran Barak
Medical Director
Abbvie
This round table highlights the significant gaps in the cardio metabolic patient journey within Israel’s Arab community, especially during the transition from hospital to community care. These gaps stem from cultural, linguistic, and systemic barriers that impact continuity of treatment and health outcomes. We will explore practical solutions to address these challenges and improve equity in cardiometabolic care.

Sharon Raymond
Public Affairs Head & Strategic Partnerships
Novartis Israel

Marina Naomi Smolyanov
Regional Innovation Manager
Clalit Health Services
